Your browser doesn't support javascript.
loading
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis.
Borozan, Ivan; Zaidi, Syed H; Harrison, Tabitha A; Phipps, Amanda I; Zheng, Jiayin; Lee, Stephen; Trinh, Quang M; Steinfelder, Robert S; Adams, Jeremy; Banbury, Barbara L; Berndt, Sonja I; Brezina, Stefanie; Buchanan, Daniel D; Bullman, Susan; Cao, Yin; Farris, Alton B; Figueiredo, Jane C; Giannakis, Marios; Heisler, Lawrence E; Hopper, John L; Lin, Yi; Luo, Xuemei; Nishihara, Reiko; Mardis, Elaine R; Papadopoulos, Nickolas; Qu, Conghui; Reid, Emma E G; Thibodeau, Stephen N; Harlid, Sophia; Um, Caroline Y; Hsu, Li; Gsur, Andrea; Campbell, Peter T; Gallinger, Steven; Newcomb, Polly A; Ogino, Shuji; Sun, Wei; Hudson, Thomas J; Ferretti, Vincent; Peters, Ulrike.
Afiliación
  • Borozan I; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Zaidi SH; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Harrison TA; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Zheng J; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Lee S; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Trinh QM; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Steinfelder RS; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Adams J; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Banbury BL; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Brezina S; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Bullman S; The University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Cao Y; Familial Cancer Clinic, Genetic Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Farris AB; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Figueiredo JC; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Giannakis M; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St Louis, Missouri.
  • Heisler LE; Siteman Cancer Center, Washington University School of Medicine in St. Louis, St Louis, Missouri.
  • Hopper JL; Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Lin Y; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Luo X; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Nishihara R; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Mardis ER; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Papadopoulos N; The University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Qu C; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Reid EEG; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Thibodeau SN; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Harlid S; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Um CY; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Hsu L; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio.
  • Gsur A; Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, Maryland.
  • Campbell PT; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Gallinger S; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Newcomb PA; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Ogino S; Oncology, Department of Radiation Sciences, Faculty of Medicine, Umeå University, Umeå, Sweden.
  • Sun W; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.
  • Hudson TJ; Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
  • Ferretti V; Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington.
  • Peters U; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Cancer Epidemiol Biomarkers Prev ; 31(1): 210-220, 2022 01.
Article en En | MEDLINE | ID: mdl-34737207

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Fusobacterium nucleatum Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Fusobacterium nucleatum Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá